Search Results 161-170 of 28543 for Crohns disease

1. Publications - Michael C. Stephens, M.D. - Mayo Clinic

   Distinct cutoff values of adalimumab trough levels are associated with different therapeutic outcomes in patients with inflammatory bowel disease. Crohn's & ...

2. Study to Determine Risk Factors for Post-operative Infection in Inflammatory Bowel Disease - Mayo Clinic

   Understanding of how best to treat inflammatory bowel disease (IBD) ... Evidence now suggests that the most effective therapy early in the course of Crohn's ...

3. A Study to Evaluate Long-Term Safety and Effectiveness of HUMIRA (Adalimumab) in Pediatric Patients with Moderately to Severely Active Crohn's Disease - Mayo Clinic

   ... and effectiveness of adalimumab in pediatric patients with moderately to severely active crohn's disease ... and stage of disease, and previous treatments ...

4. A Bio-bank for Patients with Inflammatory Bowel Disease Associated Neoplasia - Mayo Clinic

   The purpose of this study is to collect blood and stool samples to validate and improve the performance of stool and blood DNA markers for inflammatory bowel ...

5. IBD and Women's Health Intervention - Mayo Clinic

   About this study. The purpose of this research study is to assess women who are diagnosed with Inflammatory Bowel Disease (IBD) and study the combination of ...

6. A Study to Evaluate the Long-Term Effectiveness, Safety, and Tolerability of Repeated Administration of ABT-494 in Patients with Crohn's Disease - Mayo Clinic

   ... and Tolerability of Repeated Administration of ABT-494 in Patients with Crohn's Disease ... and stage of disease, and previous treatments or health concerns.

7. Intestinal obstruction - Symptoms & causes - Mayo Clinic

   Inflammatory bowel diseases, such as Crohn's disease · Diverticulitis — a condition in which small, bulging pouches (diverticula) in the digestive tract become ...

8. Immuno-Epigenetics: William A. Faubion Jr.

   ... the autoimmune inflammatory bowel diseases (IBDs), such as Crohn's disease (CD) and ulcerative colitis (UC). Despite some genetic variation associated with IBD ...

9. A Study to Evaluate the Safety and Effectiveness of Risankizumab in Subjects with Moderately to Severely Active Crohn's Disease - Mayo Clinic

   A Study to Evaluate the Safety and Effectiveness of Risankizumab in Subjects with Moderately to Severely Active Crohn's Disease ... and stage of disease, and ...

10. A Placebo-Controlled Study of Oral Ozanimod as Maintenance Therapy for Moderately to Severely Active Crohn's Disease - Mayo Clinic

    ... Crohn's Disease. Participation eligibility. Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns.